^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

HBM1022

i
Other names: HBM1022
Associations
Trials
Company:
Harbour BioMed
Drug class:
CCR8 inhibitor
Associations
Trials